Olaparib and ovarian cancer-overall survival outcomes.
Institute of Cancer and Genomics, University of Birmingham, Birmingham B15 2TT, UK. Electronic address: s.t.kehoe@bham.ac.uk.
Sean
S
Kehoe
D005260:Female; D006801:Humans; D010051:Ovarian Neoplasms; D010793:Phthalazines; D010879:Piperazines
D010793:Phthalazines; D010879:Piperazines; C531550:olaparib